Walking and breathing are examples of essential human behaviour that is controlled by the nervous system and powered by contractions of skeletal muscles.
Neuromuscular disorders refers to a broad range of conditions in which the communication between the central nervous system and skeletal muscle fails, and patients develop debilitating weakness and fatigue.
In patients with neuromuscular disorders the loss of muscle functionality leads to reduced mobility and lack of independence and, in turn, markedly reduced quality of life. In severely affected patients the muscle weakness can lead to life-threatening respiratory problems.
Our vision is to improve the quality of life and survival of patients with neuromuscular disorders.
To achieve this, NMD Pharma is on a mission to develop novel treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders.